Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
NCT06687603
This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to develop a method to detect Barrett's esophagus in individuals with a new office based diagnostic test. Barrett's esophagus is a condition in which the flat pink lining of the swallowing tube that connects the mouth to the stomach (the esophagus) becomes damaged by acid reflux. The main question it aims to answer is: Can this approach demonstrate efficacy for screening of Barrett's esophagus? Participants will: Participate in a questionnaire. Undergo a capsule balloon test, called EsoCheck.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Barrett Esophagus
- Gastroesophageal Reflux
- Esophageal Adenocarcinoma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Case Comprehensive Cancer Center
- Last updated on ClinicalTrials.gov
- September 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- University of Colorado · Aurora, CO
Maryland · 1
- Johns Hopkins Hospital · Baltimore, MD
North Carolina · 1
- University of North Carolina at Chapel Hill · Chapel Hill, NC
Ohio · 2
- Cleveland Clinic Taussig Cancer Center · Cleveland, OH
- University Hospitals Cleveland Medical Center · Cleveland, OH
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.